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Abstract 
Rationale: Primary ciliary dyskinesia (PCD) is an inherited disorder characterized by 
heterogeneous airway disease. Traditional lung function techniques (e.g. spirometry) may 
underestimate severity and complexity of PCD.  
Objectives: We assessed lung impairment in individuals with PCD using structural and 
functional magnetic resonance imaging (MRI) and different lung function techniques. 
Methods: Thirty study participants with PCD (median 13.4 years, range 5–28) underwent 
structural and functional MRI, spirometry, and multiple breath washout (MBW) on the same 
day. Primary endpoints included structural MRI morphology scores, relative ventilation and 
perfusion impairment from functional MRI, FEV1 from spirometry, and lung clearance index 
(LCI) from MBW.  
Results: Severity and complexity of PCD lung disease varied significantly between individuals. 
Structural lung disease was detected in all subjects with a median (IQR) extent score of 10.3 (7 
to 19; maximum score = 60). Functional MRI ventilation impairment was present in 52% of 
subjects affecting 24.2% (21.1 to 25.2%) of the lung. Relative perfusion impairment was 
detected in 78% of individuals affecting 21.1% (19.4 to 25.9%) of the lung. LCI was abnormal in 
83% (median 8.3 (2.6 to 13.2) z-scores) and FEV1 was abnormal in 27% (-0.5 (-1.6 to 0.3) z-
scores) of individuals. Concordance between spirometry and imaging outcomes was poor, with 
52% of patients showing both abnormal MRI and LCI values, but normal FEV1. 
Conclusions: Discordance between lung function and imaging outcomes in patients with PCD 
supports the use of both imaging and lung function, such as MBW, for surveillance of this 
heterogeneous disease.  
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Primary ciliary dyskinesia (PCD) is an autosomal recessive inherited disorder of considerable 
clinical and genetic heterogeneity (1). The main feature of PCD is decreased airway clearance 
due to impaired ciliary motility (2). This results in localized airway infections, ventilation 
defects, and heterogeneous impairments to pulmonary function and structure (1, 3-5). A major 
challenge of the current clinical care in PCD is the ability to detect and monitor subclinical lung 
disease (5, 6). Spirometry has been traditionally used to assess airflow limitation (7-9), while 
the multiple breath washout (MBW) technique is more sensitive to detect subclinical small 
airway disease (10). Still, lung function tests alone cannot differentiate between reversible and 
irreversible structural defects and may underestimate disease severity.  
Lung imaging is thus needed to directly assess the presence and extent of structural lung 
disease in individuals with PCD. High-resolution computed tomography (HR-CT) is considered 
the gold standard for assessing structural abnormalities in lung disease (7, 11, 12). However, 
HR-CT scans expose individuals to ionizing radiation and functional information from HR-CT 
scans is limited (13, 14). Beside HR-CT, Magnetic resonance imaging (MRI) techniques can 
provide information on structural and functional deficits in the lung without radiation exposure 
(15). Traditionally functional MRI techniques were constrained by the need for intravenous or 
inhaled contrast agents (16-20). However, recently developed matrix pencil (MP) 
decomposition MRI method can be used to assess ventilation and perfusion defects in the lung 
during free tidal breathing and without the need for contrast agents (21). We have previously 
shown that the functional MP-MRI method is sensitive to detect lung ventilation and perfusion 
impairment in children with cystic fibrosis (CF), and there is a high degree of correlation 
between lung structure and function outcomes in this population (15). We hypothesized that 
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functional MP-MRI will also detect impairment of ventilation and perfusion in individuals with 
PCD. Specifically we aimed to assess (i) the prevalence and extent of lung function and structure 
abnormalities, and (ii) the concordance and correlation between lung function and structural 
outcomes in individuals with PCD. Some of the data have been presented previously in abstract 
form (22). 
 
Methods  
 
Study Design 
This is a prospective cross-sectional, single-centre observational study. Recruitment took place 
between April 2015 and February 2016. Study participants underwent spirometry, nitrogen 
multiple breath washout (N2-MBW), structural MRI, and functional MP-MRI on the same day. 
 
Study Population 
We enrolled 30 study participants with PCD, aged 5–28 years (median age 13.4 years) at the 
University Children`s Hospital of Ruhr University Bochum, St Josef Hospital, Germany. All study 
participants had a confirmed diagnosis of PCD according to current guidelines and clinical 
symptoms coherent to PCD diagnosis (5, 23, 24) (Table 1, E1). Eligibility criteria included the 
absence of acute pulmonary exacerbation during the last three weeks prior to the study (25). 
The study was approved by the Ethics Committee of the Ruhr University Bochum (Number: 
5103). We obtained written informed consent from parents and assent from study participants 
if older than 14 years.  
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MRI Data Acquisition and Evaluation 
All MRI examinations were performed on a 1.5 Tesla whole-body MR-scanner (MAGNETOM 
Avanto-Fit, Siemens Healthineers, Erlangen, Germany) using a 12-channel thorax and a 24-
channel spine receiver coil array. Both structural and functional MRI were obtained during free 
breathing and without the use of contrast agents within a single MR session. Sedation was not 
required for MRI assessment, even for the youngest patient (aged 5 years).  
 
Morphological MRI 
The Eichinger MRI morphology score was used to assess the presence and extent of structural 
lung disease (26). The structural defects assessed include bronchiectasis/bronchial wall 
thickening, mucus plugging, abscess/sacculation, special findings and consolidation. Individual 
features are scored as follows: 0 = not present; 1 = present and affecting ≤ 50% of the lobe; 2 = 
present and affecting > 50% of the lobe. The lobe scores for each component were summed to 
produce a score out of 12. The total morphology score is composed of five sub-scores each with 
a maximum score of 12 (maximum score = 60). The morphological MRI datasets were scored by 
two board-certified, fellowship-trained radiologists with 9 and 14 years of experience in cross-
sectional imaging of the chest. Further details are provided in the online supplement (Table E2).  
 
Functional MRI 
Functional MRI imaging was performed using the recently developed matrix pencil 
decomposition method (MP-MRI), which is a derivative of the Fourier decomposition MRI 
technique (27-30). Functional MRI imaging was performed using time-resolved acquisitions 
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with an ultra-fast steady-state free precession (ufSSFP) pulse sequence during relaxed 
breathing. The matrix pencil decomposition method was applied to generate maps of regional 
fractional ventilation, which reflects changes of lung parenchyma density during respiration, 
and regional perfusion maps, which reflects changes in blood flow in the lung (21, 30). The 
distribution of ventilation and perfusion was assessed and a threshold was applied to 
determine the degree of impairment (15, 29). The relative fractional ventilation (RFV) and 
relative perfusion (RQ) impairment were calculated and expressed as a percentage of lung 
volume for each study participant. In order to estimate the degree of functional abnormalities 
in patients with PCD we relied on historical normal values for MRI (15).  
Further details are provided in the online supplement. 
 
Lung Function Assessment 
Spirometry. Spirometry was performed using Jaeger MasterScreen bodyplethysmograph 
equipment (CareFusion, Hochberg, Germany) according to current guidelines (8). We assessed 
the forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) and calculated z-
scores from recommended reference equations for spirometry (31). 
Multiple breath washout (MBW). The nitrogen multiple breath washout (N2-MBW) 
technique was performed using a commercially available device (Exhalyzer D, Eco Medics AG, 
Duernten, Switzerland) (32) and in accordance with current consensus guidelines (33, 34). The 
primary outcome was the lung clearance index (LCI). Secondary outcomes included Scond and 
Sacin, which reflect convection and diffusion-convection dependent ventilation inhomogeneity, 
respectively. We calculated z-scores for the N2-MBW based on published reference values (9). 
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Statistical Analysis 
Visual inspection of the distribution of our data indicated significant skewing, therefore the 
data were expressed as medians and interquartile ranges (IQRs). To assess the prevalence and 
concordance of structural and functional outcomes we defined abnormality at ±1.64 z-scores 
for spirometry and MBW outcomes(35), structural MRI sub-scores ≥ 2 points (indicates >15% 
structural impairment) (36), and functional MRI outcomes RFV ≥ 24.2% and RQ ≥ 19.3% according 
to healthy reference data (15). We described concordance for the entire population using a 
Venn diagram and further in four study participants to illustrate clinical phenotypes. 
Spearman`s rank correlation coefficients (r) were used to assess correlations between 
structural and functional outcomes (correlations definitions: weak (0.10-0.29), moderate (0.30-
0.49) and strong (>0.50)) (37). We used the mean morphological scores from both readers to 
assess the extent of structural lung disease. Inter-observer agreement was calculated using the 
intra class correlation coefficient (ICC). P-values <0.05 were considered statistically significant. 
Analyses were performed using Stata (Stata Statistical Software: Release 13. College Station, TX: 
StataCorp LP). Graphs were drawn with Stata and MATLAB (2012b, The MathWorks, Natick, 
MA, US). Additional details are provided in the online supplement. 
 
Results 
 
All thirty subjects with PCD were able to perform spirometry, N2-MBW, and MRI on the same 
day. The clinical characteristics of the study participants are presented in Table 1 and Table E1.  
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Data Quality  
After quality control, all 30 study participants had morphological MRI, N2-MBW and spirometry 
data, and 27 study participants had functional MRI data, included in the final analysis. Further 
details are provided in the online supplement. 
 
Magnetic Resonance Imaging 
Structural lung abnormalities were present in all study participants. The proportion of study 
participants with bronchiectasis/ bronchial wall thickening was 97% and mucus plugging was 
60% (Table 2). The total morphology score ranged from 3 to 28 and the median (IQR) score for 
the population was 10.3 (7 to 19). The bronchiectasis/bronchial wall thickening scores ranged 
from 1.5 to 10.5 and the median (IQR) score was 6 (4.5 to 8). The mucus plugging score ranged 
from 0.5 to 8.5 and the median (IQR) score was 2.3 (1 to 4). We found a predominance of 
defects in the middle and lower lobes (Table E3). The agreement between structural MRI 
readers was good with an ICC of 0.67 for the total morphology score (Table E2).  
The proportion of study participants with functional MRI ventilation impairment was 
52% and perfusion impairment was 78%. The relative proportion of the lung with impaired 
ventilation (RFV) (median (IQR)) was 24.2% (21.1 to 25.2) and relative perfusion (RQ) was, 21.1% 
(19.4 to 25.9) (Table 2).  
 
Lung Function  
The ability to capture abnormal lung function strongly varied between techniques. The 
proportion of subjects with abnormal values was 27% for FEV1, 83% for LCI, 63% for Scond, and 
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50% for Sacin. The median (IQR) of FEV1 z-score was -0.5 (-1.6 to 0.3), LCI was 8.3 (2.6 to 13.2) z-
score, Scond 2.8 (0.9 to 4.4) z-score, and Sacin 1.7 (0.4 to 6.7) z-score (Table 3).  
 
Concordance between Lung Function and MRI on Group and Individual Level 
More than half of the patients (52%) had structural lung disease, functional MRI impairment 
and abnormal LCI values, but FEV1 values within the normal range (Figure 1). Only 15% of 
subjects had concordant abnormalities in all primary outcome measures. In terms of 
concordance between two primary outcomes, LCI and total morphology score were 
concordantly abnormal in 25 of 30 (83%) subjects, mucus plugging and LCI were concordantly 
abnormal in 15/30 (50%) subjects, and LCI and RQ were concordantly abnormal in 19/27 (70%) 
subjects.  
To illustrate the complexity of PCD lung disease, MRI and lung function from four 
individual study participants are presented in Table E4. Subjects 1 and 2 had FEV1 values within 
the normal limits, while subjects 3 and 4 had abnormal FEV1. In contrast, subjects 1 and 4 had 
normal LCI values, while subjects 2 and 3 had pathological LCI values, which differed in severity 
of 7.3 and 24.0 z-scores, respectively. Morphological MRI scores also differed between these 
subjects. Patient 2 is a 28 year-old female (morphology score = 5) who had rarefaction of the 
lung parenchyma in the upper lobes, resembling emphysematous changes (a finding that is not 
captured by score). Patient 3 showed more extensive bronchiectasis/ bronchial wall thickening 
without atelectasis (score = 26). Both these subjects had poorly perfused and ventilated lung 
regions, although functional impairment on MRI was more pronounced in Patient 3. The results 
from these study participants are outlined in Table E4, Figure 1 and Figure 2. 
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Correlation between Structure and Function Outcomes 
Lung function and functional MRI outcomes cannot distinguish between reversible (mucus 
plugging) and partly irreversible (bronchiectasis/bronchial wall thickening) structural changes 
(Figure 3, Figure E1 and E2). There were no statistically significant correlations between 
functional MRI and lung function outcomes (Figure 4 and Table E5). However, we found 
statistically significant, moderate correlations between the total morphology scores and LCI (r = 
0.54, p = 0.002) and FEV1 (r = -0.59, p < 0.001) (Table E5, Figure E3).  
 
Discussion  
 
We used comprehensive imaging and function methods to assess lung disease in individuals 
with PCD. PCD lung disease is characterized by highly prevalent structural pathology with 
heterogeneous functional consequences. Structural lung disease, functional MRI impairment, 
and abnormal LCI were present in the majority of patients. FEV1, however, was not sensitive 
enough to detect structural airway disease in this population. Our findings highlight the 
heterogeneous nature of PCD lung disease and the need for a multi-modality approach to 
characterize and potentially monitor patients with PCD. 
 
Comparison with Previous Literature 
We assessed structural lung abnormalities in patients with PCD using morphological MRI. 
Previous studies have only used HR-CT imaging to characterize structural lung disease in 
patients with PCD (7, 11). However, studies have shown that MRI can reliably assess structural 
Page 11 of 46  ANNALSATS Articles in Press. Published on 05-October-2018 as 10.1513/AnnalsATS.201712-967OC 
 Copyright © 2018 by the American Thoracic Society 
  
lung disease in patients with CF lung disease (18, 38) and demonstrated good agreement 
between HR-CT and MRI in patients with PCD (39). We found that the prevalence and extent of 
structural lung abnormalities in patients with PCD was similar to what we reported in patients 
with CF (15). Therefore, our results indicate that morphological MRI scans can provide a 
radiation-free method to assess structural lung disease in individuals with PCD. 
We found that the correlation between lung structure and function outcomes were 
weaker in patients with PCD compared with those we reported in patients with CF. Structural 
lung abnormalities e.g. bronchiectasis/bronchial wall thickening were present in 97% of all 
subjects, while 78% of subjects had abnormal LCI and only 27% had abnormal FEV1. Previous 
studies using HR-CT have reported a strong correlation between LCI and CT morphology scores 
(r = 0.8) (7), while another reported no correlation (11). The conflicting nature of these data 
also suggest a multi-modality approach to fully and reliably characterize PCD lung disease.  
The major advantage of the functional MRI technique used in our study is that it 
provides data on ventilation and perfusion impairment in the lung without the need for 
contrast agents or breath-hold manoeuvres (18, 20). This is the first time this technique has 
been used to assess functional lung impairment in patients with PCD. In contrast to patients 
with CF, we did not find a correlation between perfusion and ventilation indices from the 
functional MRI and lung function outcomes in patients with PCD (15). A previous study used 
hyperpolarised gas MRI to assess lung ventilation defects in patients with PCD and reported 
good correlations between imaging and lung function outcomes (LCI and FEV1/FVC) (20). Lung 
impairment in patients with PCD is frequently focal in nature with lobar or segmental 
atelectasis. Focal pathology is difficult to capture by lung function techniques that assess global 
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airflow or ventilation impairment. We determined in our analysis that middle and lower lobe 
were more severely (score = 2) and more predominant affected than the upper lobe. This is in 
line with previously studies which showed typical imaging features in PCD including a 
predominance of bronchiectasis in the middle and lower lobes (40, 41) presumably due to 
greater difficulty in the drainage of secretions. Therefore, relationships between lung imaging 
and function outcomes can be influenced by the heterogeneity of the disease in individuals 
with PCD (42). Further work to define morphological and functional scoring systems specific for 
the focal nature of lung disease in individuals with PCD is needed. 
 
Clinical Relevance 
We recruited individuals with PCD diagnosed based on current European consensus 
recommendations (5, 23, 24). Our patient population included a wide age range, with a variety 
of disease severities, and therefore represents a typical PCD population in tertiary care centres. 
We provide further evidence that FEV1 is not sensitive to monitor structural airway pathologies 
in patients with PCD. The LCI from the MBW technique appears to be more sensitive to monitor 
early structural lung disease, however, LCI values were not able to distinguish between 
individuals with reversible and partly irreversible structural disease. Therefore, in patients with 
normal lung function, lung imaging may be needed to detect early and focal structural changes. 
Structural and functional MRI are sensitive tools to monitor lung disease progression and 
responses to treatment without the need for radiation exposure or the risks associated with 
intravenous contrast agents. 
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Strengths and Limitations 
All study participants enrolled in our study were able to perform MRI scans and lung function 
tests within a one-day clinic visit. All MR images were obtained without sedation, contrast 
agent or breathing maneuvers which can be difficult in younger or uncooperative subjects. We 
included thirty study participants with clear and fulfilled PCD diagnostic criteria. The sample size 
is comparable to previous studies and is sufficient to allow meaningful interpretation of the 
data (7, 11, 15). The patients with PCD in our study were younger (mean 13.4 (range 10.4 to 
17.1), than the patients in the study of Boon (16.1 (11.1 to 19.6) years) and Irving (mean age of 
24.7), and therefore have a milder lung disease compared with the older patients in these 
studies. We did not include retrospective chest CT scans as this data was not available within a 
reasonable time before the MRI scans to allow meaningful comparison. We used an established 
MRI CF score to evaluate structural disease in study participants with PCD (26). The ICC 
between scorers was good in our study. However, PCD specific CT and MRI morphology scorings 
systems are currently not available. Peripheral bronchiectasis without bronchial wall thickening, 
and discrete mucus plugging of small airways cannot be well visualized by MRI (14). In addition, 
hyperinflation of the lung may be underestimated using a CF scoring system. We did not recruit 
prospective healthy controls in this study but relied on previously published normative data 
from our group using the same equipment for both MRI and lung function outcomes (15). 
Furthermore, the automatic functional lung evaluation method as used in this work relies on 
segmentation of the whole lung volume in order to calculate global ventilation or perfusion 
impairment. Currently, no lobar segmentation method is available as it poses a significant 
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challenge in comparison to well-established lobar segmentation methods known from 
computed tomography. 
 
Outlook 
Sensitive and feasible techniques for functional lung MRI in children are now available. We 
encourage the use of MRI for future investigative studies in patients with PCD to allow for 
better understanding of this complex lung disease. Future interventional trials should consider 
the use of a combination of novel MRI techniques and lung function outcomes to collectively 
monitor responses to treatments in PCD lung disease.  
 
Conclusion 
In summary, we assessed airflow limitation, ventilation, perfusion, and structural airway 
impairment in patients with PCD using novel MRI sequences without the need for contrast 
agents or breathing manoeuvres. The poor correlation between spirometry and imaging 
outcomes in our study supports the use of both MRI and sensitive lung function techniques to 
assess lung disease in individuals with PCD. While LCI was more sensitive to detect lung disease 
than FEV1, LCI was not able to discriminate between reversible and irreversible airway disease 
in our study. Longitudinal studies using a combination of MRI and LCI may help to understand 
the complex relationships between PCD genotypes, ciliary function phenotypes, lung 
morphology and functional impairment.   
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Figure Legends 
 
Figure 1. Venn diagram of PCD phenotypes. Venn diagrams for PCD phenotypes are clustered 
accordingly. Colored circles represent the different imaging and lung function modalities. [Lung 
Clearance index (LCI) from the nitrogen multiple breath washout, yellow; Sub-score of 
bronchiectasis and bronchial wall thickening from structural MRI, red; Forced expiratory volume 
in 1 second (FEV1) from spirometry, blue; relative perfusion impairment (RQ) from functional 
MRI, green; abnormal values are given in percentage]. ULN/LLN are defined as: LCI≥1.64 z-
scores, FEV1≤-1.64 z-scores, Sub-score of structural MRI ≥ 2 points, and RQ≥19.3%. Numbers 
listed where circles overlap are common abnormal values in the respective modalities. 
Numbers do not sum up to 100%, because the overlap between functional and structural MRI is 
not displayed in the graph. Study participants from Figure 2 and Table E4 are marked as P1-P4. 
 
Figure 2. Individual phenotypes. Sample images from (a) morphological T2-weighted structural 
MRI and (b-c) functional matrix pencil decomposition MRI including: (b) fractional ventilation 
(FV) maps, (c) perfusion-weighted (Q) maps. Low intensity regions (black and blue) on FV and Q 
maps correspond to regions with reduced signal amplitudes at respiratory and cardiac 
frequencies indicating functional defects (d and e). High values of fractional ventilation or 
perfusion are represented by yellow and red on the functional maps. Patient 1: Atelectasis of 
middle lobe and lingula with associated defects in Q and delay in blood arrival time (BAT). 
Moderate bronchial wall thickening and bronchiectasis in the lower lobes. FV defects are larger 
and in slightly different location (upper lobes) than expected from morphology. Age: 13 years; 
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nNo: 106,6 nl/min; TEM: IDA defect; Genetics: homozyg. DNAI1 mut. c.1232A>C. Patient 2: situs 
inversus, emphysematous changes of the apical parts of both lungs with associated decrease in 
Q. Mild to moderate bronchial wall thickening in both lower lobes with decreased homogeneity 
of Q and decrease in FV. Age: 28 years; nNo: 33 nl/min; TEM: not available; Genetics: not 
available. Patient 3: situs inversus, extensive bronchial wall thickening, bronchiectasis and 
mucus plugging in right lower lobe, lingula and middle lobe associated with defects in Q and FV 
and delayed BAT. Moderate changes of the left lower lobe. Minor changes of the upper lobes. 
Age: 22 years; nNo: 6.2 nl/min; TEM: ODA defect+tubul. disorg.; Genetics: homozyg. DNAH5 
mut. ex.55 c.9346C>T. Patient 4: moderate bronchial wall thickening, bronchiectasis and mucus 
plugging with predominance in the lower lobes. Matched Q and FV abnormalities. Age: 8 years; 
nNo: 49.8 nl/min; TEM: IDA/ODA defect; Genetics: not available. 
 
Figure 3. Lung clearance index (LCI) and structural MRI scores. Study participants with PCD were 
additionally divided in two groups by the sub-score mucus plugging: hollow circles indicate 
those study participants without relevant mucus plugging (<2 points in the sub-score mucus 
plugging) and closed circles indicate those study participants with relevant mucus plugging (≥2 
points in the sub-score mucus plugging).  
 
Figure 4. Lung clearance index (LCI) and functional MRI indices. A: Lung clearance index (LCI) 
and ventilation (RFV) impairment of the lung as percentage. B: Lung clearance index (LCI) and 
perfusion (RQ) impairment of the lung as percentage. 
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Table 1 Clinical characteristics of study participants with PCD (N=30) 
General characteristics    
Age at diagnosis (yr.; median (IQR)) 
Age at study enrollment (yr.; median (IQR)) 
4.2 (0.9 to 8.5) 
13.4 (10.4 to 17.1) 
Sex, n (males/females) 14/16 
Height, cm 152.2 (138.5 to 167.3) 
Weight, kg 49.8 (37.2 to 63.5) 
Situs inversus 14  (47%) 
a
Diagnostics  
High-frequency-video microscopy (HVM) available  29 (97%) 
Immotile 16  (55%) 
Dyskinetic  13  (45%) 
other 0 
Transmission electron microscopy (TEM) available  24 
ultrastructural abnormality
 
 16  ( 66,7%) 
inconclusive 2 (8,3%) 
normal 6 (25%) 
Not available 6 (20%) 
Nasal nitric oxide (nNO) measurement done 30 (100%) 
nNO median (min - max) in nl/min 18,7  (2,7 – 303,3) 
subjects with low level <77 nl/min 26  (87%) 
subjects with normal level >77nl/min 4  (13%) 
Immunofluorescence (IF) with PCD defect identified    
Genetic analysis with PCD defect identified 
16 
18 
a 
For further diagnostic details see online supplement (Table E1) 
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Table 2 Functional and morphological MRI outcomes from study participants with PCD 
Eichinger score (morphological MRI) 
                 Median (IQR) Range * 
Prevalence 
of abnormal 
values 
Total score (60 points) 
Score 10.3 (7 to 19) 3 to 28  
Bronchiectasis/ bronchial wall thickening/ (12 points) 
Sub-score 6 (4.5 to 8) 1.5 to 10.5 29/30 (97%) 
Mucus plugging (12 points) 
Sub-score 2.3 (1 to 4) 0.5 to 8.5 18/30 (60%) 
Consolidation (12 points) 
Sub-score 1.5 (0 to 3) 0 to 4.5 14/30 (47%) 
Abscess/Sacculation (12 points) 
Sub-score 0 (0 to 0) 0.5 to 1  0/30 (0%) 
Special findings (12 points) 
Sub-score 0 (0 to 0.5) 0 to 4.5 2/30 (7%) 
 
Functional MRI (MP-MRI) 
Ventilation defect  
RFV (%) 24.2 (21.1 to 25.2) 16.7 to 28.7  14/27 (52%) 
Perfusion defect  
RQ (%) 21.1 (19.4 to 25.9) 13.8 to 28.4 21/27 (78%) 
All results are expressed as median (IQR), range, and percentage. A dedicated MRI score 
(Eichinger score) was used for morphological scoring. We used the mean of the morphological 
scores from two readers. The functional MRI (MP-MRI) gives results of the impairment of 
perfusion (RQ) and ventilation (RFV) in percentage of the lung volume. *The upper limit of 
normality was defined as ≥ 2 points for the sub-scores; for functional MRI indices ULN was used 
from published values (15). 
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Table 3 Lung function outcomes in study participants with PCD  
 Median (IQR) Range * Prevalence of 
abnormal values 
N2-MBW 
LCI [lung turnover] 10.8 (8.2 to 13.0) 6.6 to 17.9  
LCI [z-score] 8.3 (2.6 to 13.2) -0.9 to 24 25/30 (83%) 
Scond  0.05 (0.03 to 0.07) 0 to 0.1  
Scond [z-score] 2.8 (0.9 to 4.4) -1.6 to 5.9 19/30 (63%) 
Sacin 0.11 (0.08 to 0.26) 0.03 to 0.38  
Sacin [z-score] 1.7 (0.4 to 6.7) -1.0 to 11.0 15/30 (50%) 
Spirometry 
FEV1 % pred. 99.1 (83.5 to 106.8) 28.9 to 113.6  
FEV1 [z-score] -0.5 (-1.6 to 0.3) -5.7 to 0.77 8 (27%) 
All results are expressed as median (IQR), range, and percentage. Outcome parameters from 
lung function measurements: lung clearance index (LCI); Scond and Sacin, normalized phase III 
slope indices (see methods for explanation) and forced expiratory volume in 1 second (FEV1). 
*ULN/LLN is defined as ± 1.64 z-score.  
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Venn diagrams for PCD phenotypes are clustered accordingly. Colored circles represent the different imaging 
and lung function modalities. [Lung Clearance index (LCI) from the nitrogen multiple breath washout, 
yellow; Sub-score of bronchiectasis and bronchial wall thickening from structural MRI, red; Forced expiratory 
volume in 1 second (FEV1) from spirometry, blue; relative perfusion impairment (RQ) from functional MRI, 
green; abnormal values are given in percentage]. ULN/LLN are defined as: LCI≥1.64 z-scores, FEV1≤-1.64 
z-scores, Sub-score of structural MRI ≥ 2 points, and RQ≥19.3%. Numbers listed where circles overlap are 
common abnormal values in the respective modalities. Numbers do not sum up to 100%, because the 
overlap between functional and structural MRI is not displayed in the graph. Study participants from Figure 2 
and Table E4 are marked as P1-P4.  
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Sample images from (a) morphological T2-weighted structural MRI and (b-c) functional matrix pencil 
decomposition MRI including: (b) fractional ventilation (FV) maps, (c) perfusion-weighted (Q) maps. Low 
intensity regions (black and blue) on FV and Q maps correspond to regions with reduced signal amplitudes 
at respiratory and cardiac frequencies indicating functional defects (d and e). High values of fractional 
ventilation or perfusion are represented by yellow and red on the functional maps.  
Patient 1: Atelectasis of middle lobe and lingula with associated defects in Q and delay in blood arrival time 
(BAT). Moderate bronchial wall thickening and bronchiectasis in the lower lobes. FV defects are larger and in 
slightly different location (upper lobes) than expected from morphology. Age: 13 years; nNo: 106,6 nl/min; 
TEM: IDA defect; Genetics: homozyg. DNAI1 mut. c.1232A>C.  
Patient 2: situs inversus, emphysematous changes of the apical parts of both lungs with associated decrease 
in Q. Mild to moderate bronchial wall thickening in both lower lobes with decreased homogeneity of Q and 
decrease in FV. Age: 28 years; nNo: 33 nl/min; TEM: not available; Genetics: not available.  
Patient 3: situs inversus, extensive bronchial wall thickening, bronchiectasis and mucus plugging in right 
lower lobe, lingula and middle lobe associated with defects in Q and FV and delayed BAT. Moderate changes 
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defect+tubul. disorg.; Genetics: homozyg. DNAH5 mut. ex.55 c.9346C>T.  
Patient 4: moderate bronchial wall thickening, bronchiectasis and mucus plugging with predominance in the 
lower lobes. Matched Q and FV abnormalities. Age: 8 years; nNo: 49.8 nl/min; TEM: IDA/ODA defect; 
Genetics: not available.  
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Study participants with PCD were additionally divided in two groups by the sub-score mucus plugging: 
hollow circles indicate those study participants without relevant mucus plugging (<2 points in the sub-score 
mucus plugging) and closed circles indicate those study participants with relevant mucus plugging (≥2 
points in the sub-score mucus plugging).  
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A: Lung clearance index (LCI) and ventilation (RFV) impairment of the lung as percentage.  
B: Lung clearance index (LCI) and perfusion (RQ) impairment of the lung as percentage.  
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 26 
Methods  27 
Morphological MRI 28 
The readers were blinded to the patients’ clinical symptoms and history. Diagnostic quality of 29 
each image data set was rated on a 4-point Likert scale with 0 indicating the lowest (poor) and 30 
3 the highest (excellent) image quality. The morphological MRI datasets were read by two 31 
board-certified, fellowship-trained radiologists with 9 and 14 years of experience in cross-32 
sectional imaging of the chest. In brief, the Eichinger Score divided each lung into 6 lobes 33 
(with the lingula considered as a separate lobe) and scored for the presence of bronchiectasis/ 34 
bronchial wall thinkening in a central and peripheral zone. Central zone 35 
bronchiectasis/bronchial wall thickening: luminal diameter > corresponding artery; peripheral 36 
zone: visibility of bronchi within 1 cm of the pleural surface. Mucus plugging: area with a 37 
diameter greater than 0.3 cm. Abscess/sacculations: air filled or air fluid level within a 38 
minimum diameter of 1.5 cm. Consolidation: parenchym signal of the lung >2 cm, Special 39 
findings pleural effusion or reaction(1). The radiologist scores each disease parameter 40 
(bronchiectasis, mucus plugging, abscess and consolidation) separately in the lung as follows: 41 
0 = not present; 1 = present, affecting ≤ 50% of the lobe; 2 = present, affecting > 50% of the 42 
lobe. The lobe scores for each component were summed to produce a score out of 12. The 43 
total score was defined as the sum of all scores. 44 
 45 
Functional MRI 46 
MP MRI technique (2) allows for simultaneous assessment of regional pulmonary perfusion 47 
and fractional ventilation without the need for the administration of an intravenous or inhaled 48 
contrast agents. Functional imaging was performed using time-resolved acquisitions with an 49 
ultra-fast steady-state free precession (ufSSFP) pulse sequence (3, 4). Multiple coronal slices 50 
were acquired in order to cover the whole lung volume. Neither ECG nor any respiratory 51 
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triggering method is required during the scan. MP decomposition technique takes advantage 52 
from variations of regional MR signal intensity in the lung tissue caused by respiratory and 53 
cardiac cycles. In the inspiration the regional lung volume increases while the signal intensity 54 
decreases. The opposite takes place during expiration. Thus, the signal intensity in the lung is 55 
determined by the phase of the respiratory cycle and can be scaled linearly in the tidal volume 56 
breathing region. The signal intensity in the lung parenchyma is also modulated by the cardiac 57 
cycle. Fresh unsaturated blood entering the slice being imaged increases the regional signal 58 
intensity. Both physiological cycles correspond to different frequencies and can be spectrally 59 
retrieved in the time-resolved dataset. However, prior to further post-processing, the acquired 60 
datasets are subject to elastic image registration for the compensation of respiratory motion. 61 
Subsequently, pixel-wise spectral analysis is performed on the motion-corrected data using 62 
the MP decomposition to identify frequency components of the physiological cycles. Matrix 63 
pencil (MP) decomposition method was applied to generate maps of regional fractional 64 
ventilation, which reflects changes of lung parenchyma density during respiration, as well as 65 
relative perfusion maps. The signal distributions on the functional images in the segmented 66 
region of interests were analyzed to estimate threshold values indicating a functional 67 
impairment of 75% of the median value of the voxel distributions.  68 
69 
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Results 70 
 71 
Data Quality 72 
 73 
Morphological MRI 74 
The average diagnostic quality of the morphological MRI data sets was good (average score = 75 
2.0) with 26 datasets rated excellent (score 3), 25 good (score 2) and 9 fair (score 1).  76 
 77 
Functional MRI 78 
Due to logistic reasons, no functional images were obtained in three patients. All MR images 79 
included into the analysis were of sufficient diagnostic quality. 80 
 81 
  82 
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Legend to the figures 83 
 84 
Figure E1 85 
FEV1 and structural MRI sub-scores for bronchiectasis/bronchial wall thickening. Patients 86 
with PCD were additionally divided in two groups by the sub-score mucus plugging: hollow 87 
circles indicate those patients without relevant mucus plugging (<2 points in the sub-score 88 
mucus plugging) and closed circles indicate those patients with relevant mucus plugging (≥2 89 
points in the sub-score mucus plugging).  90 
 91 
Figure E2 92 
Relative perfusion impairment (RQ) and structural MRI sub-scores for 93 
bronchiectasis/bronchial wall thickening. Patients with PCD were additionally divided in two 94 
groups by the sub-score mucus plugging: hollow circles indicate those patients without 95 
relevant mucus plugging (<2 points in the sub-score mucus plugging) and closed circles 96 
indicate those patients with relevant mucus plugging (≥2 points in the sub-score mucus 97 
plugging).  98 
 99 
Figure E3 100 
Lung clearance index (LCI) and structural MRI total scores   101 
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Table E1  Patients‘ diagnostic features including causative mutations 
Patient Situs anNO bHFVM bTEM IF Genetics Comments 
1 si normal 
(251,7 
nl/min) 
3x mildly dyskinetic 
(uncoordinated 
beating pattern, 
winding movement) 
1x normal,  
1x reduced 
ODA/IDA 
Lack of 
CCDC11 
and 
DNALI1 
homozygous loss of 
function CCDC11 
mutation c.121C>T 
bronchiectasis in 
right lower lobe, 
bronchial wall 
thickening in 
both lower lobes 
2 si normal 
(303,4 
nl/min) 
2x mildly dyskinetic 
(uncoordinated 
beating pattern, 
reduced amplitude) 
2x missing of 
central pairs 
in 30% of 
cilia, 1x + 
ODA defect + 
reduced /IDA 
Lack of 
DNAH5 
homozygous loss of 
function CCDC11 
mutation c.121C>T 
bronchial wall 
thickening in 
middle lobe, 
elevated LCI 
3 ss low 2x immotile ODA/IDA 
defect, + in 
20% missing 
of central 
pairs 
not done homozygous 
DNAH5 mutation 
c.8757G>C, + two 
heterozygous 
mutations: in  
DNAI1 c.48+2dupT 
and in DNAAF3 
c.296C>G 
 
4 ss low 2x dyskinetic IDA/ODA 
defect 
DNAH5 
and GAS8 
present 
awaiting results  
5 si low 2x immotile with 
some fasciculation 
normal not done awaiting results one additional 
sibling affected 
(not included in 
the study), also 
situs inversus, 
low nNO  
6 ss low immotile with some 
fasciculation 
IDA/ODA 
defect 
Lack of 
DNAH5 
not done  
7 si low immotile with some 
fasciculation 
IDA/ODA 
defect + 
tubulus 
dysorganizat. 
DNAH5 
staining 
abnormal 
homozygous 
ARMC4 mutation 
c.2675C>A 
 
8 si low 2x immotile not done not done not done typical PCD 
phenotype 
including 
neonatal distress, 
and middle lobe 
atelectasis 
9 si low immotile with some 
fasciculation 
IDA/ODA 
defect 
Lack of 
DNAH5 
2 DNAH5 mutations 
c.8029C>T and 
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c.10615C>T 
10 si low immotile normal Lack of 
DNAH5 
2 DNAH5 mutations 
c.13194_13197del 
and c.10615C>T 
 
11 si low immotile ODA defect + 
tubulus 
dysorganizat. 
not done homozygous 
DNAH5 mutation 
ex.55 c.9346C>T 
 
12 ss low 2x immotile ODA defect + 
reduced IDAs 
Lack of 
DNAH5 
homozygous 
DNAH5 mutation 
c.2224C>T 
 
13 ss low 2x dyskinetic normal DNAH5 
limited to 
ciliary 
base 
homozygous DNAI1 
mutation c.48+2insT 
 
14 si low 2x immotile with 
some fasciculation  
not done not done awaiting results neonat distress, 
middle lobe 
atelectasis, 
radioaerosole 
mucociliary 
clearance test 
pathological 
15 ss low 2x immotile with 
some fasciculation 
2x IDA defect 
+ tubulus 
dysorganizat. 
not done homozygous 
CCDC39 mutation 
c.610_613delTTAG 
 
16 ss low immotile ODA defect Lack of 
DNAH5 
not done  
17 ss normal 
(106,6 
nl/min) 
2x dyskinetic 
(uncoordinated and 
reduced frequency) 
2x IDA defect not known homozygous DNAI1 
mutation c.1232A>C 
 
18 si low 2x immotile result not 
known (done 
in native 
country) 
Lack of 
DNAH5 
SPAG1 heterozygous 
mutation p.Q672* 
and 11kb deletion 
 
19 si low too few ciliated  
cells 
too few cilia not done homozygous 
nonsense DNAH5 
mutation c.2224C>T 
for p.Arg742X 
 
20 ss low 2x immotile normal Lack of 
DNAH5 
2 DNAH5 mutations 
c.5710-2A>G and 
c.10815delT 
 
21 ss low 2x immotile with 
some fasciculation 
IDA/ODA 
defect 
Lack of 
DNAH5 
not done  
22 si normal 
(84,8 
nl/min) 
very fast (>16Hz) 
beating, reduced 
amplitude + 
backwards 
movement 
1x normal,  
1x slightly 
reduced IDAs 
DNAH5,  
GAS8 and 
RSPH9 
normal 
2 mutations in 
DNAH11 
c.1710+1G>C and 
c.8920A>G 
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23 ss low 2x immotile ODA defect not done homozygous 
DNAH5 mutation 
c.6057delT and 
heterozygous 
DNAH11 mutation 
c.9469C>T 
Sibling of 24 
24 si low 2x immotile ODA defect, 
IDAs slightly 
reduced 
not done homozygous 
DNAH5 mutation 
c.6057delT 
Sibling of 23 
25 si low dyskinetic 
(uncoordinated, 
reduced amplitude) 
IDAs missing Lack of 
DNAH5 
and 
DNALI1 
homozygous 
DYX1C1 mutation 
c.583delA 
 
26 ss low 2x: dyskinetic (slow  
uncoordinated 
beating), same as 
sibling (patient 27) 
not done not done not done Sibling of 27 
27 ss low 2x: dyskinetic (slow  
uncoordinated 
beating), same as 
sibling (patient 26) 
not done not done not done Sibling of 26 
28 ss low 2x dyskinetic normal Lack of 
DNAH5 
not done (lives 
abroad) 
Sibling of 29, 
situs inversus in 
a third PCD-
affected sibling 
(not in study as 
too young for 
lung function) 
29 ss low 2x dyskinetic normal Lack of 
DNAH5 
not done (lives 
abroad) 
Sibling of 28, 
situs inversus in 
a third PCD-
affected sibling 
(not included in 
this study) 
30 ss low 2x dyskinetic ODA defect Lack of 
DNAH5 
not done (lives 
abroad) 
 
a measurements done at least on 3 occasions, b “2x” etc. indicates the number of performed tests, si= situs inversus, ss= situs 
solitus. 
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Table E3 Distribution of MRI structural anomalies in upper vs. middle vs. lower lobes 
Table E2 Morphological MRI scoring from two readers  
Eichinger score (morphological MRI) 
 Reader 1 Reader 2 ICC (95%CI) 
Total score 
Score 11 (9 to 18) 8.5 (5 to 20) 0.67 (0.44 to 0.82) 
Bronchiectasis/  bronchial wall thickening 
Subscore 7 (6 to 8) 5 (3 to 7) 0.51 (0.27 to 0.75) 
Mucus plugging 
Subscore 3 (1 to 5) 2(1 to 4) 0.78 (0.60 to 0.89) 
Consolidation 
Subscore 2 (0 to 3) 2 (0 to 3) 0.82 ( 0.67 to 0.91) 
Abscess/Sacculation 
Subscore 0 (0 to 0) 0 (0 to 0)  
Special findings 
Subscore 0 (0 to 1) 0 (0 to 0) 0.43 ( 0.18 to 0.71) 
All results are expressed as median (+ IQR) or as ICC (95% CI). A dedicated MRI score (Eichinger score) was used for 
morphological scoring. Reading was performed by two independent radiologists: Reader 1 and Reader 2. Interobserver 
agreement was calculated by using the intraclass correlation coefficient (ICC). 
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 Bronchiectasis/ bronchial wall thickening Mucus plugging 
Score 0  1 2 0 1 2 
Right lung 
Upper lobe 7 (23%) 22 (73%) 1 (3%) 28 (93%) 2 (7%) - 
Middle lobe 2 (7%) 12 (40%) 16 (53%) 11 (37%) 10 (33%) 9 (30%) 
Lower lobe -  17 (57%) 13 (43%) 11 (37%) 15 (50%) 4 (13%) 
Left lung 
Upper lobe 5 (17%) 24 (80%) 1 (3%) 25 (83%) 5 (17%) - 
Lower lobe 2 (7%) 18 (60%) 10 (33%) 18 (60%) 9 (30%) 3 (10%) 
Lingula  7 (23%) 14 (47%) 9 (30%) 19 (63%) 6 (20%) 5 (17%) 
Bronchiectasis/bronchial wall thickening and mucus plugging with detailed count of patients with PCD N (%). Detailed scoring from 
Reader 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table E4 Concordance between different modalities on an individual level in four study participants with PCD 
 
Patient 1 Patient 2 Patient 3 Patient 4 
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Age, years 13 28 22 8 
Gender male female female male 
                                                    Normal spirometry 
 
           Abnormal spirometry 
 
FEV1 [%] 104 109 84 83 
FEV1 [z-score] -0.08 0.36 -1.64 -1.67 
FVC [z-score] -0.83 1.41 -0.03 -2.50 
Multiple breath washout 
 
LCI 7.6 10.3 17.9 6.6 
LCI [z-score] 1.3 7.3 24 -0.9 
Functional MRI 
RFV [%] 22.4 24.9 28.7 23.9 
RQ [%] 18.6 24.2 28.0 28.4 
Morphological MRI 
Main characteristics Atelectasis 
 
Emphysematous Bronchiectasis and 
mucus plugging 
 
Mixed morphology 
 
Bronchial wall 
thickening and mucus 
plugging  
Moderate Mild to moderate Extensive Moderate 
Atelectasis Middle lobe (complete), 
Lingula (partial) 
  Left upper lobe 
(subsegmental) 
 
Eichinger score 24 5 26 10 
Situs type normal situs inversus situs inversus normal 
Diagnostics 
nNO in nl/min 106.6 33 6.2 49.8 
TEM IDA defect not available  ODA defect and 
tubul. disorg. 
IDA/ODA defect 
Genetic analysis homozyg. DNAI1 mut. 
c.1232A>C. 
not available  Homozygous DNAH5 
mut. ex. 55 c. 
9346C>T 
mutations 
 not available 
Pathological values are marked in bold. 
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Table E5 Correlation between lung function parameters with MRI-defined morphological and functional abnormalities in patients with PCD  
  MRI-defined morphological indices Functional MRI indices 
  Subscores Impairment of 
ventilation (RFV) 
(r, p-value) 
Impairment of 
perfusion (RQ) 
(r, p-value) 
Indices  Total score  
(r, p-value) 
Bronchiectasis/ Bronchial  
wall thickening 
(r, p-value) 
Mucus plugging 
(r, p-value) 
Consolidation 
(r, p-value) 
Abscess/Sacculation 
(r, p-value) 
Special 
findings 
(r, p-value) 
 
LCI 0.54, 0.002 0.55, 0.002 0.41, 0.026 0.36, 0.050 0.04, 0.841 0.35, 0.057 -0.05, 0.793 0.34, 0.081 
Scond 0.18, 0.3506 0.22, 0.238 0.23, 0.222 0.29, 0.115 -0.22, 0.237 0.007, 0.972 -0.27, 0.167 0.26, 0.182 
Sacin 0.28, 0.140 0.27, 0.152 0.32, 0.080 0.08, 0.656 0.41, 0.023 0.28, 0.133 -0.18, 0.376 -0.01,0.947 
FEV1 -0.59, <0.001 -0.54, 0.002 -0.61, <0.001 -0.46, 0.011 -0.32, 0.088 -0.45, 0.012 0.13, 0.527 -0.37, 0.060 
Significant correlations (Spearman correlation coefficients) are marked in bold.  P-values < 0.05 were considered statistically significant. Correlation between dedicated morphology MRI score 
(mean from both readers) and ventilation (RFV) , perfusion (RQ) impairment of the lung from functional MRI (MP-MRI) with different lung function outcomes: lung clearance index (LCI); Scond, and 
Sacin, normalized phase III slope indices (see methods for explanation) and forced expiratory volume in 1 second (FEV1). 
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FEV1 and structural MRI sub-scores for bronchiectasis/bronchial wall thickening. Patients with PCD were 
additionally divided in two groups by the sub-score mucus plugging: hollow circles indicate those patients 
without relevant mucus plugging (<2 points in the sub-score mucus plugging) and closed circles indicate 
those patients with relevant mucus plugging (≥2 points in the sub-score mucus plugging).  
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thickening. Patients with PCD were additionally divided in two groups by the sub-score mucus plugging: 
hollow circles indicate those patients without relevant mucus plugging (<2 points in the sub-score mucus 
plugging) and closed circles indicate those patients with relevant mucus plugging (≥2 points in the sub-
score mucus plugging).  
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